NIOX Group Plc (AIM:NIOX)
London
· Delayed Price · Currency is GBP · Price in GBX 67.60
-0.40 (-0.59%)
Apr 28, 2026, 4:35 PM GMT
NIOX Group Revenue
In the year 2025, NIOX Group had annual revenue of 48.70M GBP with 16.51% growth. NIOX Group had revenue of 23.50M in the half year ending December 31, 2025, with 30.56% growth.
Revenue
48.70M
Revenue Growth
+24.87%
P/S Ratio
5.84
Revenue / Employee
502.06K
Employees
97
Market Cap
284.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 48.70M | 6.90M | 16.51% |
| Dec 31, 2024 | 41.80M | 5.00M | 13.59% |
| Dec 31, 2023 | 36.80M | 5.50M | 17.57% |
| Dec 31, 2022 | 31.30M | 3.40M | 12.19% |
| Dec 31, 2021 | 27.90M | 4.00M | 16.74% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Craneware | 157.02M |
| Avacta Group | 113.00K |
| PureTech Health | 4.66M |
| Integrated Diagnostics Holdings | 122.36M |